Breast cancer

Medicine

Volumn 40, Issue 1, 2012, Pages 5-9

  Davies, Eleri Lloyd ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

adjuvant therapy; biological markers; breast cancer; Herceptin; oncoplastic; sentinel node biopsy

Indexed keywords

ANTHRACYCLINE; BEVACIZUMAB; BIOLOGICAL MARKER; BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GOSERELIN; LAPATINIB; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ALCOHOL CONSUMPTION; ALOPECIA; ARTICLE; BIOLOGICAL THERAPY; BONE MARROW SUPPRESSION; BONE SCINTISCANNING; BREAST CANCER; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARDIOTOXICITY; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIETARY INTAKE; DNA REPAIR; EARLY DIAGNOSIS; EXERCISE; FOLLOW UP; GENE MUTATION; GOLD STANDARD; GROUPS BY AGE; HEART FAILURE; HISTOPATHOLOGY; HUMAN; INFERTILITY; INTRADUCTAL CARCINOMA; LIFESTYLE; MASTECTOMY; METASTASIS; NAUSEA; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; RECURRENCE RISK; RISK REDUCTION; SENTINEL LYMPH NODE BIOPSY; TREATMENT FAILURE;

EID: 83755219447     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2011.09.010     Document Type: Review

References (14)

1. E. Ramak, and L. Brazil Cost of managing women presenting with stage 1V breast cancer in the United Kingdom Br J Cancer 91 2004 77 83 (Pubitemid 39013048)
2. M. Dowsett, and A.K. Dunbler Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer Clin Cancer Res 14 2008 8019 8026
3. National Institute for Health and Clinical Excellence Guidance on breast cancer (early and locally advanced): diagnosis and treatment 2009 NICE London Also available at: http://guidance.nice.org/CG80
4. L. Turnbull, S. Brown, and I. Harvey Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised control trial Lancet 355 2010 563 571
5. C. Boetes, J. Veltman, L. van Die, P. Bult, T. Wobber, and J.O. Barentsz The role of MRI in invasive lobular carcinoma Breast Cancer Res Treat 86 2004 31 37 (Pubitemid 38918896)
6. M. Kaufman, L. Puztai, and Biedenkopf Expert Panel Members Use of standard markers and incorporation of molecular markers in breast cancer therapy: consensus recommendation from an international expert panel Cancer 117 2011 1575 1582
7. R. Menta, R.K. Jain, and S. Badve Personalized medicine: the road ahead Clin Breast Cancer 11 2011 20 26
8. D. Elfadl, V. Gavimella, T.K. Mahapatra, P.L. McManus, and P.J. Drew Lipomodelling of the breast: a review Breast 19 2010 202 209
9. J.J. Chen, B.C. Yang, and J.X. Zhang A prospective comparison of molecular assay and touch imprint cytology for intraoperative evaluation of sentinel lymph nodes Clin Med J (Engl) 124 2011 491 497
10. M. Clarke, R. Collins, and S. Darby Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomised trials Lancet 366 2005 2087 2106 (Pubitemid 41797643)
11. J.S. Vaidya, D.J. Joseph, and J.S. Tobias Targeted intra-operative radiotherapy versus breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial Lancet 376 2010 91 102
12. Early Breast Cancer Trials' Collaborative Group (EBCTG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of randomised control trials Lancet 365 2005 1687 1717
13. J. Cuzick, I. Sestak, and M. Baum Effect of anastrazole and tamoxifen as adjuvant treatment for early stage breast cancer: 10 year analysis of ATAC trial Lancet Oncol 11 2010 1135 1141
14. M.J. Piccart-Gebhart, M. Procter, and B. Leyland-Jones Trastuzumab after adjuvant chemotherapy in Her2 positive patients N Engl J Med 353 2005 1659 1672 (Pubitemid 41464705)